Cargando…
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
BACKGROUND: While antibodies can provide significant protection from SARS-CoV-2 infection and disease sequelae, the specific attributes of the humoral response that contribute to immunity are incompletely defined. METHODS: We employ machine learning to relate characteristics of the polyclonal antibo...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851712/ https://www.ncbi.nlm.nih.gov/pubmed/35172720 http://dx.doi.org/10.1186/s12865-022-00480-w |
_version_ | 1784652877597245440 |
---|---|
author | Natarajan, Harini Xu, Shiwei Crowley, Andrew R. Butler, Savannah E. Weiner, Joshua A. Bloch, Evan M. Littlefield, Kirsten Benner, Sarah E. Shrestha, Ruchee Ajayi, Olivia Wieland-Alter, Wendy Sullivan, David Shoham, Shmuel Quinn, Thomas C. Casadevall, Arturo Pekosz, Andrew Redd, Andrew D. Tobian, Aaron A. R. Connor, Ruth I. Wright, Peter F. Ackerman, Margaret E. |
author_facet | Natarajan, Harini Xu, Shiwei Crowley, Andrew R. Butler, Savannah E. Weiner, Joshua A. Bloch, Evan M. Littlefield, Kirsten Benner, Sarah E. Shrestha, Ruchee Ajayi, Olivia Wieland-Alter, Wendy Sullivan, David Shoham, Shmuel Quinn, Thomas C. Casadevall, Arturo Pekosz, Andrew Redd, Andrew D. Tobian, Aaron A. R. Connor, Ruth I. Wright, Peter F. Ackerman, Margaret E. |
author_sort | Natarajan, Harini |
collection | PubMed |
description | BACKGROUND: While antibodies can provide significant protection from SARS-CoV-2 infection and disease sequelae, the specific attributes of the humoral response that contribute to immunity are incompletely defined. METHODS: We employ machine learning to relate characteristics of the polyclonal antibody response raised by natural infection to diverse antibody effector functions and neutralization potency with the goal of generating both accurate predictions of each activity based on antibody response profiles as well as insights into antibody mechanisms of action. RESULTS: To this end, antibody-mediated phagocytosis, cytotoxicity, complement deposition, and neutralization were accurately predicted from biophysical antibody profiles in both discovery and validation cohorts. These models identified SARS-CoV-2-specific IgM as a key predictor of neutralization activity whose mechanistic relevance was supported experimentally by depletion. CONCLUSIONS: Validated models of how different aspects of the humoral response relate to antiviral antibody activities suggest desirable attributes to recapitulate by vaccination or other antibody-based interventions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12865-022-00480-w. |
format | Online Article Text |
id | pubmed-8851712 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88517122022-02-18 Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2 Natarajan, Harini Xu, Shiwei Crowley, Andrew R. Butler, Savannah E. Weiner, Joshua A. Bloch, Evan M. Littlefield, Kirsten Benner, Sarah E. Shrestha, Ruchee Ajayi, Olivia Wieland-Alter, Wendy Sullivan, David Shoham, Shmuel Quinn, Thomas C. Casadevall, Arturo Pekosz, Andrew Redd, Andrew D. Tobian, Aaron A. R. Connor, Ruth I. Wright, Peter F. Ackerman, Margaret E. BMC Immunol Research BACKGROUND: While antibodies can provide significant protection from SARS-CoV-2 infection and disease sequelae, the specific attributes of the humoral response that contribute to immunity are incompletely defined. METHODS: We employ machine learning to relate characteristics of the polyclonal antibody response raised by natural infection to diverse antibody effector functions and neutralization potency with the goal of generating both accurate predictions of each activity based on antibody response profiles as well as insights into antibody mechanisms of action. RESULTS: To this end, antibody-mediated phagocytosis, cytotoxicity, complement deposition, and neutralization were accurately predicted from biophysical antibody profiles in both discovery and validation cohorts. These models identified SARS-CoV-2-specific IgM as a key predictor of neutralization activity whose mechanistic relevance was supported experimentally by depletion. CONCLUSIONS: Validated models of how different aspects of the humoral response relate to antiviral antibody activities suggest desirable attributes to recapitulate by vaccination or other antibody-based interventions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12865-022-00480-w. BioMed Central 2022-02-16 /pmc/articles/PMC8851712/ /pubmed/35172720 http://dx.doi.org/10.1186/s12865-022-00480-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Natarajan, Harini Xu, Shiwei Crowley, Andrew R. Butler, Savannah E. Weiner, Joshua A. Bloch, Evan M. Littlefield, Kirsten Benner, Sarah E. Shrestha, Ruchee Ajayi, Olivia Wieland-Alter, Wendy Sullivan, David Shoham, Shmuel Quinn, Thomas C. Casadevall, Arturo Pekosz, Andrew Redd, Andrew D. Tobian, Aaron A. R. Connor, Ruth I. Wright, Peter F. Ackerman, Margaret E. Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2 |
title | Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2 |
title_full | Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2 |
title_fullStr | Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2 |
title_full_unstemmed | Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2 |
title_short | Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2 |
title_sort | antibody attributes that predict the neutralization and effector function of polyclonal responses to sars-cov-2 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851712/ https://www.ncbi.nlm.nih.gov/pubmed/35172720 http://dx.doi.org/10.1186/s12865-022-00480-w |
work_keys_str_mv | AT natarajanharini antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT xushiwei antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT crowleyandrewr antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT butlersavannahe antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT weinerjoshuaa antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT blochevanm antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT littlefieldkirsten antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT bennersarahe antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT shrestharuchee antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT ajayiolivia antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT wielandalterwendy antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT sullivandavid antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT shohamshmuel antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT quinnthomasc antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT casadevallarturo antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT pekoszandrew antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT reddandrewd antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT tobianaaronar antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT connorruthi antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT wrightpeterf antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 AT ackermanmargarete antibodyattributesthatpredicttheneutralizationandeffectorfunctionofpolyclonalresponsestosarscov2 |